Search

everythinglearnresearchcommunity

for

Search:↓

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Plant roots respond to fungus smells by possibly using certain proteins and a plant hormone to change root growth, but more research is needed.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Nilotinib can cause generalized keratosis pilaris.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

The drug combination was safe and showed promise in treating advanced tumors.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Certain drugs can change hair color, either lightening or darkening it.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Gefitinib can cause hair and eyebrow darkening.

Some drugs can cause permanent hair loss, though it's rare.

Deucravacitinib helped a man regrow hair significantly.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Targeting the Smoothened receptor shows promise for treating certain cancers.

LGR5 mainly stays inside cells, moving to the trans-Golgi network, and this process is important for its role in cell signaling.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

The compound 4c showed strong potential as an anticancer agent.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

A mutant FERONIA gene affects root hair growth at high temperatures.

Lung cancer biology differs between women and men, with women responding better to certain treatments.

Using existing drugs for new purposes can effectively treat infections resistant to multiple antibiotics.

Premature hair graying is caused by genetics, stress, and lifestyle, and affects mental health.